Latest Filings

Issuer Activity

Insider Overview :: Verisante Technology, Inc. (V:VRS) [?]
Business Focus: Advanced Medical Equipment & Technology
Recent Price for VRS
CAD 0.385 +0.03 (+6.49%)
TSXV Delayed 15 minutes
May 17 1559 EDT
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.640 0.0 N/A 27.19
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.365 0.0% 105,991  
Log in or sign up for a free account to add this stock to your watch list.
Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 17th, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
Jan 3/13 Dec 27/12 Braun, Thomas Andrew Direct Ownership Options 50 - Grant of options 275,000  
Dec 28/12 Dec 27/12 Trinh, Anna Thi Kieu My Direct Ownership Options 50 - Grant of options 100,000  
Dec 28/12 Dec 27/12 Thiessen, Jacob (Jake) James Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Dennis, Christopher John Wesley Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Boodram, Karen Francia Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Biegel, Joseph David Direct Ownership Options 50 - Grant of options 75,000  
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -280,500 $0.500
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -55,000 $0.510
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -143,500 $0.520
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -18,500 $0.530
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 17th, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
Jan 3/13 Dec 27/12 Braun, Thomas Andrew Direct Ownership Options 50 - Grant of options 275,000  
Jan 3/13 Nov 13/09 Braun, Thomas Andrew Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Dec 28/12 Dec 27/12 Trinh, Anna Thi Kieu My Direct Ownership Options 50 - Grant of options 100,000  
Dec 28/12 Dec 27/12 Thiessen, Jacob (Jake) James Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Dennis, Christopher John Wesley Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Boodram, Karen Francia Direct Ownership Options 50 - Grant of options 75,000  
Dec 28/12 Dec 27/12 Biegel, Joseph David Direct Ownership Options 50 - Grant of options 75,000  
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -280,500 $0.500
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -55,000 $0.510
Dec 17/12 Dec 12/12 Braun, Thomas Andrew Indirect Ownership Common Shares 10 - Disposition in the public market -143,500 $0.520
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for VRS on May 17, 2013 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
Key People
Thomas A. Braun
President, Chief Executive Officer, Chief Business Development Officer, Director 		Anna Trinh
Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary 		 
Company Contact
Address: Suite 306, 2309 West 41st Avenue
VANCOUVER BC V6M 2A3
Tel: --
Website: www.verisante.com
IR: www.verisante.com/invest
Business Overview
Verisante Technology, Inc. (Verisante), formerly T-Ray Science, Inc., is a medical device company. The Company focuses in the commercialization of systems for the early detection of cancer. The Company's device Verisante Aura is used for the detection of all forms of skin cancer, including basal cell carcinoma, squamous cell carcinoma and melanoma. The Company's product portfolios include Verisante Aura and Verisante Core. Verisante Aura is an imaging and spectroscopy system designed to aid in the detection of skin cancer. Verisante Core uses an endoscopic attachment to aid in the detection of lung, colon, cervical and other cancers. Verisante Core series, detects spectral bio-markers for cancer.
Competitors with Recent Insider Filings
Titan Medical (V:TMD)
IMRIS (T:IM)
MedX Health (V:MDX)
 
Verisante Technology, Inc. Insider Report Only $20.00